Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin	Acid-Base Imbalance, Ketosis, Nutritional and Metabolic Diseases, acidosis disorder, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus	Not yet recruiting	Phase 2	2025-11-06		NCT07225465

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Austin Health	17
Baker Heart and Diabetes Institute	13
Melbourne Health	12
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
St Vincent's Hospital Melbourne	9
University of Melbourne	71

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Austin Health	Heidelberg	Australia	70
Baker Heart and Diabetes Institute	Melbourne	Australia	17
St Vincent's Hospital Melbourne	Fitzroy	Australia	27
The Royal Melbourne Hospital	Parkville	Australia	26